Anthem Biosciences Limited is a leading innovation-driven Contract Research, Development, and Manufacturing Organization (CRDMO) that provides fully integrated solutions across the pharmaceutical value chain—from drug discovery and development to manufacturing. Headquartered in Bangalore, India, Anthem supports a global clientele, including emerging biotech innovators and major pharmaceutical giants.
Founded in 2006, the company has established itself as a key player in specialized fermentation-based APIs, covering a wide range of products such as probiotics, enzymes, peptides, vitamin analogues, nutritional actives, and biosimilars.
As of September 30, 2024, Anthem was engaged in 196 active projects spanning various stages of the drug development lifecycle:
- 🔍 170 discovery projects, with 284 unique molecules synthesized,
- 🚀 132 early-phase development initiatives,
- 🧪 16 late-phase programs focused on 10 near-market molecules,
- 🏭 13 commercial manufacturing projects supporting 10 launched drugs.
The company’s global footprint is underscored by its robust customer base of over 550 clients across more than 44 countries, including the U.S., Europe, and Japan.
Anthem Biosciences is also deeply invested in innovation, with 8 granted patents (1 in India and 7 overseas) and 24 global patent applications pending, covering areas like glycolipid synthesis and GLP-1 analogues.
With a strong team of 600+ experts, including medicinal chemists, microbiologists, molecular biologists, biochemists, and chemical engineers, Anthem maintains a science-first approach while delivering scalable and reliable solutions to its partners.
This high-growth company is now taking its next big leap with a public listing, aiming to unlock further potential in the global life sciences ecosystem.
Anthem Biosciences IPO – Details
| IPO Opening Date | 14 July 2025 |
| IPO Closing Date | 16 July 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 5,95,61,404 Shares Worth ₹3,395.00 Crore Offer For Sale: 5,95,61,404 Shares Worth ₹3,395.00 Crore |
| Face Value | ₹2 per equity share |
| IPO Price | ₹540 – ₹570 per share |
| Market Lot | 26 Shares |
| Min Order | 26 Shares [ 1 LOT ] |
| Employee Discount | ₹50 |
| Listing At | BSE, NSE |
| Register | Kfin Technologies Limited |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Anthem Biosciences IPO – Date Schedule
| IPO Open Date | 14 July 2025 |
| IPO Close Date | 16 July 2025 |
| Basis of Allotment | 17 July 2025 |
| Initiation of Refund | 18 July 2025 |
| Credit of Shares to Demat Account | 18 July 2025 |
| IPO Listing Date | 21 July 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 16, 2025 |
Anthem Biosciences IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 26 | ₹14,820 |
| Retail (Max) | 13 | 338 | ₹1,92,660 |
| S-HNI (Min) | 14 | 364 | ₹2,07,480 |
| S-HNI (Max) | 67 | 1,742 | ₹9,92,940 |
| B-HNI (Min) | 68 | 1,768 | ₹10,07,760 |
Competitive Strength
- One-stop service across the drug life cycle (discovery, development, manufacturing) for small molecules and biologics; we are India’s fastest growing CRDMO.
- Innovation-focused approach has enabled us to offer a spectrum of technologically advanced solutions across modalities and manufacturing practices.
- Specialized business model for small pharmaceutical and biotech companies, from discovery to manufacturing.
- Long-standing relationships with a large, diversified and loyal customer base.
- Professional and experienced leadership team supported by a qualified scientific talent pool.
Company Promoters
- Ajay Bhardwaj
- Ganesh Sambasivam
- K Ravindra Chandrappa
- Ishaan Bhardwaj
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2023 | ₹1,133.99 Cr | ₹698.50 Cr | ₹385.19 Cr | ₹125.06 Cr |
| 31 March 2024 | ₹1,483.07 Cr | ₹1,005.75 Cr | ₹367.31 Cr | ₹232.53 Cr |
| 31 March 2025 | ₹1,930.28 Cr | ₹1,273.42 Cr | ₹451.26 Cr | ₹108.95 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 20.82% |
| ROCE | 26.88% |
| Debt/Equity | 0.05 |
| RoNW | 20.82% |
| PAT Margin | 23.38% |
| EBITDA Margin | 36.81% |
| Price to Book Value | 13.23 |
| Pre IPO | Post IPO | |
| EPS (₹) | 8.07 | 8.07 |
| P/E (x) | 70.62 | 70.62 |
Object Of The Issue
- The Company will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.
Anthem Biosciences IPO Peer Comparison
| S. No. | Face Value | Company Name | P/E |
|---|---|---|---|
| 1 | 10 | Syngene International Ltd | 51.54 |
| 2 | 1 | Sai Life Sciences Ltd | 92.18 |
| 3 | 1 | Cohance Lifesciences Ltd | 97.29 |
| 4 | 2 | Divi’s Laboratories Ltd | 83.22 |
✅Strengths
- Integrated CRDMO across discovery, development, and manufacturing.
- Robust growth with high margins and strong profitability.
- Advanced tech capabilities (flow chemistry, biotransformation).
- Sustainability focus – 89% renewable energy use.
- Global presence with 550+ clients in 44+ countries.
- Commercial portfolio includes high-value patented molecules.
⚠️Risks
- Strict regulatory compliance in global markets.
- High customer concentration – loss of key clients may impact revenue.
- Quality control lapses may lead to recalls or penalties.
- Dependence on key personnel and technical staff.
- Competitive pricing pressure in the CRDMO space.
Anthem Biosciences IPO Promoter Holding
| Pre Issue Share Holding | 77.23% |
| Post Issue Share Holding | 74.68% |
Anthem Biosciences IPO Prospectus
Company Contact Information
| Anthem Biosciences Ltd. No. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase 1, Bommasandra, Bengaluru, Karnataka, 560099 Phone: +91 080 6672 400 Email: investors.abl@anthembio.com Website: https://www.anthembio.com/ |
Anthem Biosciences IPO Registrar
| Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: anthem.ipo@kfintech.com Website: https://kosmic.kfintech.com/ipostatus/ |
Anthem Biosciences IPO Lead Manager(s)
| 1. JM Financial Limited 2. J.P. Morgan India Private Limited 3. Citigroup Global Markets India Private Limited 4. Nomura Financial Advisory and Securities (India) Private Limited |
Anthem Biosciences IPO FAQs
| What is Anthem Biosciences IPO? Anthem Biosciences IPO is a main-board IPO. The issue is priced at ₹540 to ₹570 per equity share. The IPO is to be listed on BSE & NSE. |
| When Anthem Biosciences IPO will open? The IPO is to open on 14 July 2025 for QIB, NII, and Retail Investors. |
| What is Anthem Biosciences IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Anthem Biosciences IPO? You can apply Anthem Biosciences IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Anthem Biosciences IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Anthem Biosciences IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Anthem Biosciences IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Anthem Biosciences IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Anthem Biosciences IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Anthem Biosciences IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Anthem Biosciences IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Anthem Biosciences IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Anthem Biosciences IPO Size? Anthem Biosciences IPO size is ₹3,395.00 Crore. |
| What is the Anthem Biosciences IPO Price Band? Anthem Biosciences IPO Price Band is ₹540 to ₹570. |
| What is Anthem Biosciences IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 26 Shares with ₹14,820 while the maximum bid is 338 Shares with ₹1,92,660. |
| What is the Anthem Biosciences IPO Allotment Date? Anthem Biosciences IPO allotment date is 17 July 2025. |
| What is the Anthem Biosciences IPO Listing Date? Anthem Biosciences IPO listing date is 21 July 2025. The IPO is to be listed on BSE and NSE. |
